Compare TOL & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOL | HIMS |
|---|---|---|
| Founded | 1967 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 8.9B |
| IPO Year | N/A | N/A |
| Metric | TOL | HIMS |
|---|---|---|
| Price | $133.05 | $39.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | ★ $151.60 | $44.90 |
| AVG Volume (30 Days) | 1.2M | ★ 19.8M |
| Earning Date | 12-08-2025 | 11-03-2025 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 20.76 |
| EPS | ★ 13.49 | 0.54 |
| Revenue | ★ $10,966,723,000.00 | $2,210,958,000.00 |
| Revenue This Year | $0.45 | $62.21 |
| Revenue Next Year | N/A | $18.79 |
| P/E Ratio | ★ $9.86 | $74.17 |
| Revenue Growth | 1.11 | ★ 78.02 |
| 52 Week Low | $86.67 | $23.97 |
| 52 Week High | $156.89 | $72.98 |
| Indicator | TOL | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 48.76 |
| Support Level | $136.76 | $38.24 |
| Resistance Level | $145.01 | $40.99 |
| Average True Range (ATR) | 4.11 | 2.01 |
| MACD | 0.14 | 0.84 |
| Stochastic Oscillator | 40.94 | 83.66 |
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.